- Home
- AKRO vs BL Comparison
AKRO vs BL Comparison
Compare AKRO & BL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- BL
- Stock Information
- Founded
- AKRO 2017
- BL 2001
- Country
- AKRO United States
- BL United States
- Employees
- AKRO N/A
- BL N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- BL Computer Software: Prepackaged Software
- Sector
- AKRO Health Care
- BL Technology
- Exchange
- AKRO Nasdaq
- BL Nasdaq
- Market Cap
- AKRO 3.9B
- BL 3.6B
- IPO Year
- AKRO 2019
- BL 2016
- Fundamental
- Price
- AKRO $54.58
- BL $56.28
- Analyst Decision
- AKRO Strong Buy
- BL Buy
- Analyst Count
- AKRO 6
- BL 13
- Target Price
- AKRO $82.50
- BL $58.62
- AVG Volume (30 Days)
- AKRO 1.8M
- BL 803.8K
- Earning Date
- AKRO 08-08-2025
- BL 08-05-2025
- Dividend Yield
- AKRO N/A
- BL N/A
- EPS Growth
- AKRO N/A
- BL 28.07
- EPS
- AKRO N/A
- BL 1.41
- Revenue
- AKRO N/A
- BL $662,806,000.00
- Revenue This Year
- AKRO N/A
- BL $10.08
- Revenue Next Year
- AKRO N/A
- BL $8.69
- P/E Ratio
- AKRO N/A
- BL $39.90
- Revenue Growth
- AKRO N/A
- BL 8.93
- 52 Week Low
- AKRO $21.02
- BL $40.82
- 52 Week High
- AKRO $58.40
- BL $66.25
- Technical
- Relative Strength Index (RSI)
- AKRO 68.00
- BL 57.63
- Support Level
- AKRO $53.05
- BL $53.99
- Resistance Level
- AKRO $56.49
- BL $57.11
- Average True Range (ATR)
- AKRO 2.44
- BL 1.37
- MACD
- AKRO -0.26
- BL -0.19
- Stochastic Oscillator
- AKRO 86.02
- BL 53.98
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About BL BlackLine Inc.
BlackLine Inc is engaged in providing financial accounting close solutions delivered as Software as a Service (SaaS). The Company's solutions enable its customers to address various aspects of their critical processes, including financial close & consolidation, intercompany accounting, and invoice-to-cash. The majority of the revenue of the company is earned in the United States.